NPS's Nader on Drug Research, Growth Strategy

Feb. 25 (Bloomberg) -- Francois Nader, chief excutive officer for NPS Pharmaceuticals Inc., talks about cost strategy and product development. Nader speaks with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance." Stanley Collender, managing director for Qorvis Communications LLC, also speaks. (Source: Bloomberg)

Madoff Fund Pays Administrator But Not Victims
48:31 - A firm hired by the U.S. to distribute $4 billion to victims of Bernard Madoff’s Ponzi scheme has racked up $38.8 million in billings over four years. The investors are still waiting for their first checks, though. Bloomberg's Erik Larson has more on "Bloomberg Markets." (Source: Bloomberg)
  • Target CEO Says Border Tax Could Hurt American Families
  • Wells Fargo CEO Sloan Sees 'Great Progress' Since Scandal
  • Microsoft Unveils New Version of Surface Pro Tablet